PBD-150

CAS No. 790663-33-1

PBD-150( —— )

Catalog No. M21163 CAS No. 790663-33-1

PBD-150 is an inhibitor of human glutaminyl cyclase (hQC) Y115E-Y117E variant( ki : 490 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 62 In Stock
2MG 33 In Stock
5MG 53 In Stock
10MG 86 In Stock
25MG 174 In Stock
50MG 253 In Stock
100MG 377 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PBD-150
  • Note
    Research use only, not for human use.
  • Brief Description
    PBD-150 is an inhibitor of human glutaminyl cyclase (hQC) Y115E-Y117E variant( ki : 490 nM).
  • Description
    PBD-150 is an inhibitor of human glutaminyl cyclase (hQC) Y115E-Y117E variant( ki : 490 nM).
  • In Vitro
    ——
  • In Vivo
    PBD-150 is able to reduce the deposition of pyroglutamate-modified amyloid-β peptides in brain of transgenic mouse models of Alzheimer disease, leading to a significant improvement of learning and memory in those transgenic animals.
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Beta Amyloid
  • Recptor
    glutaminyl cyclase (hQC) Y115E-Y117E
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    790663-33-1
  • Formula Weight
    320.4
  • Molecular Formula
    C15H20N4O2S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:125 mg/mL (390.13 mM; Need ultrasonic)
  • SMILES
    COc1ccc(NC(=S)NCCCn2ccnc2)cc1OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Huang K.-F Liaw S.-S Huang W.-Let al. Structures of Human Golgi-resident Glutaminyl Cyclase and Its Complexes with Inhibitors Reveal a Large Loop Movement upon Inhibitor Binding[J]. Journal of Biological Chemistry 286(14):12439-12449.
molnova catalog
related products
  • Lecanemab

    Lecanemab (BAN-2401) is an IgG1 monoclonal antibody targeting soluble aggregated β-amyloid (Abeta) with activity against oligomers, protofibrils, and insoluble protofibrils, and may be useful in the study of Alzheimer's disease (AD)-induced mild cognitive impairment and mild AD dementia.

  • β-Amyloid 29-40

    β-Amyloid (29-40) is a fragment of Amyloid-β peptide.Alzheimer's beta amyloid peptide (29-40/42) C-terminal fragments have physical and chemical properties related to those of fusion peptides of viral proteins. The fusion of liposomes can be induced by these peptides in vitro.

  • β-Amyloid 13-27

    β-Amyloid (13-27) is a peptide consisting of amino acid of 13 to 27 of beta amyloid protein. This synthetic peptide consists of amino acids 26 to 40 of beta amyloid protein. It can be used to study the kinetics of beta amyloid formation.